Clinical Trial Results

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

PHASE1 Orange, California +11 more

RECRUITING

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

NA Chicago, Illinois +5 more

RECRUITING

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

PHASE2 Birmingham, Alabama +108 more

RECRUITING

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

PHASE2 Los Angeles, California +3 more

RECRUITING

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

PHASE3 Anchorage, Alaska +286 more

RECRUITING

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

PHASE3 Birmingham, Alabama +746 more

RECRUITING

Low Field Magnetic Resonance Imaging Assessment With Outpatients

NA Kansas City, Missouri

RECRUITING

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

PHASE3 Litchfield Park, Arizona +50 more

RECRUITING

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

PHASE1, PHASE2 Downey, California +80 more

RECRUITING

C-Brace Prospective Registry

Unknown Harrison, Arkansas +75 more

RECRUITING